• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与ARPE-19细胞系相比,人干细胞衍生的视网膜色素上皮细胞作为药物筛选和临床前检测的模型。

Human Stem Cell-Derived Retinal Pigment Epithelial Cells as a Model for Drug Screening and Pre-Clinical Assays Compared to ARPE-19 Cell Line.

作者信息

Oliveira Carolina Reis, Paiva Mayara Rodrigues Brandão de, Ribeiro Marcela Coelho Silva, Andrade Gracielle Ferreira, Carvalho Juliana Lott, Gomes Dawidson Assis, Nehemy Márcio, Fialho Sílvia Ligório, Silva-Cunha Armando, Góes Alfredo Miranda de

机构信息

1Department of Biochemistry and Immunology, Federal University of Minas Gerais, Belo Horizonte, Brazil.

Faculty of Pharmacy, Federal University of Minas Gerais, Belo Horizonte, Brazil.

出版信息

Int J Stem Cells. 2021 Feb 28;14(1):74-84. doi: 10.15283/ijsc20094.

DOI:10.15283/ijsc20094
PMID:33377455
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7904525/
Abstract

BACKGROUND AND OBJECTIVES

Eye diseases have a high socioeconomic impact on society and may be one of the fields in which most stem cell-related scientific accomplishments have been achieved recently. In this context, human Pluripotent Stem Cell (hPSC) technology arises as an important tool to produce and study human Embryonic Stem cell derived-Retinal Pigmented Epithelial Cells (hES-RPE) for several applications, such as cell therapy, disease modeling, and drug screening. The use of this technology in pre-clinical phases attends to the overall population desire for animal-free product development. Here, we aimed to compare hES-RPE cells with ARPE-19, one of the most commonly used retinal pigmented epithelial immortalized cell lines.

METHODS AND RESULTS

Functional, cellular and molecular data obtained suggest that hES-RPE cells more closely resembles native RPEs compared to ARPE-19. Furthermore, hES-RPE revealed an interesting robustness when cultured on human Bruch's membrane explants and after exposure to Cyclosporine (CSA), Sirolimus (SRL), Tacrolimus (TAC), Leflunomide (LEF) and Teriflunomide (TER). On these conditions, hES-RPE cells were able to survive at higher drug concentrations, while ARPE-19 cell line was more susceptible to cell death.

CONCLUSIONS

Therefore, hES-RPEs seem to have the ability to incur a broader range of RPE functions than ARPE-19 and should be more thoroughly explored for drug screening.

摘要

背景与目的

眼部疾病对社会具有较高的社会经济影响,并且可能是近年来在干细胞相关科学成就方面取得最多成果的领域之一。在此背景下,人类多能干细胞(hPSC)技术作为一种重要工具应运而生,可用于生产和研究人类胚胎干细胞衍生的视网膜色素上皮细胞(hES-RPE),以用于多种应用,如细胞治疗、疾病建模和药物筛选。在临床前阶段使用该技术符合总体人群对无动物产品开发的需求。在此,我们旨在比较hES-RPE细胞与ARPE-19(一种最常用的视网膜色素上皮永生化细胞系)。

方法与结果

获得的功能、细胞和分子数据表明,与ARPE-19相比,hES-RPE细胞与天然视网膜色素上皮细胞更相似。此外,hES-RPE在人布鲁赫膜外植体上培养以及暴露于环孢素(CSA)、西罗莫司(SRL)、他克莫司(TAC)、来氟米特(LEF)和特立氟胺(TER)后显示出有趣的稳健性。在这些条件下,hES-RPE细胞能够在更高的药物浓度下存活,而ARPE-19细胞系对细胞死亡更敏感。

结论

因此,hES-RPE似乎比ARPE-19具有更广泛的视网膜色素上皮功能,并且应更深入地探索其用于药物筛选的潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b2db/7904525/279a56d57366/ijsc-14-1-74-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b2db/7904525/e9192a2aeac5/ijsc-14-1-74-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b2db/7904525/a49071e3653e/ijsc-14-1-74-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b2db/7904525/e507956e2312/ijsc-14-1-74-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b2db/7904525/00004ec63b45/ijsc-14-1-74-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b2db/7904525/279a56d57366/ijsc-14-1-74-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b2db/7904525/e9192a2aeac5/ijsc-14-1-74-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b2db/7904525/a49071e3653e/ijsc-14-1-74-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b2db/7904525/e507956e2312/ijsc-14-1-74-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b2db/7904525/00004ec63b45/ijsc-14-1-74-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b2db/7904525/279a56d57366/ijsc-14-1-74-f5.jpg

相似文献

1
Human Stem Cell-Derived Retinal Pigment Epithelial Cells as a Model for Drug Screening and Pre-Clinical Assays Compared to ARPE-19 Cell Line.与ARPE-19细胞系相比,人干细胞衍生的视网膜色素上皮细胞作为药物筛选和临床前检测的模型。
Int J Stem Cells. 2021 Feb 28;14(1):74-84. doi: 10.15283/ijsc20094.
2
Overexpression of integrin alpha6 and beta4 enhances adhesion and proliferation of human retinal pigment epithelial cells on layers of porcine Bruch's membrane.整合素α6和β4的过表达增强了人视网膜色素上皮细胞在猪布鲁赫膜层上的黏附与增殖。
Exp Eye Res. 2009 Jan;88(1):12-21. doi: 10.1016/j.exer.2008.09.019. Epub 2008 Oct 10.
3
The Silk Protein Sericin Promotes Viability of ARPE-19 and Induced Pluripotent Stem Cell-Derived Retinal Pigment Epithelial Cells .丝蛋白丝胶促进 ARPE-19 和诱导多能干细胞衍生的视网膜色素上皮细胞的活力。
Curr Eye Res. 2021 Apr;46(4):504-514. doi: 10.1080/02713683.2020.1809001. Epub 2020 Sep 1.
4
Comparison of FRPE and human embryonic stem cell-derived RPE behavior on aged human Bruch's membrane.比较 FRPE 和人胚胎干细胞衍生的 RPE 在老年人类 Bruch 膜上的行为。
Invest Ophthalmol Vis Sci. 2011 Jul 1;52(8):4979-97. doi: 10.1167/iovs.10-5386.
5
Bruch's membrane aging decreases phagocytosis of outer segments by retinal pigment epithelium.布鲁赫膜老化会降低视网膜色素上皮对外节段的吞噬作用。
Mol Vis. 2007 Dec 21;13:2310-9.
6
Derivation and comparative assessment of retinal pigment epithelium from human embryonic stem cells using transcriptomics.利用转录组学从人胚胎干细胞中衍生视网膜色素上皮细胞并进行比较评估。
Cloning Stem Cells. 2004;6(3):217-45. doi: 10.1089/clo.2004.6.217.
7
Advanced glycation end product (AGE) accumulation on Bruch's membrane: links to age-related RPE dysfunction.晚期糖基化终末产物(AGE)在布鲁赫膜上的积累:与年龄相关性视网膜色素上皮功能障碍的联系。
Invest Ophthalmol Vis Sci. 2009 Jan;50(1):441-51. doi: 10.1167/iovs.08-1724. Epub 2008 Aug 1.
8
Toward the defined and xeno-free differentiation of functional human pluripotent stem cell-derived retinal pigment epithelial cells.迈向功能性人多能干细胞衍生视网膜色素上皮细胞的明确且无动物成分分化。
Mol Vis. 2011 Feb 22;17:558-75.
9
Differentiation of human pluripotent stem cells to retinal pigmented epithelium in defined conditions using purified extracellular matrix proteins.在确定的条件下使用纯化的细胞外基质蛋白将人多能干细胞分化为视网膜色素上皮细胞。
J Tissue Eng Regen Med. 2013 Aug;7(8):642-53. doi: 10.1002/term.1458. Epub 2012 Apr 18.
10
Effects of concentration of amyloid β (Aβ) on viability of cultured retinal pigment epithelial cells.淀粉样β蛋白(Aβ)浓度对培养的视网膜色素上皮细胞活力的影响。
BMC Ophthalmol. 2019 Mar 8;19(1):70. doi: 10.1186/s12886-019-1076-3.

引用本文的文献

1
Liposome Encapsulation Enhances Ripasudil Therapeutic Efficacy Against Proliferative Vitreoretinal Diseases: Implications in Advanced Ocular Treatment.脂质体包封增强了ripasudil对增殖性玻璃体视网膜疾病的治疗效果:对晚期眼部治疗的启示。
Invest Ophthalmol Vis Sci. 2025 Jun 2;66(6):56. doi: 10.1167/iovs.66.6.56.
2
Ion channels research in hPSC-RPE cells: bridging benchwork to clinical applications.人胚胎干细胞视网膜色素上皮细胞的离子通道研究:从基础研究到临床应用的桥梁。
J Transl Med. 2024 Nov 27;22(1):1073. doi: 10.1186/s12967-024-05769-5.
3
Initial Characterization of WDR5B Reveals a Role in the Proliferation of Retinal Pigment Epithelial Cells.

本文引用的文献

1
Human pluripotent stem cells: A toolbox to understand and treat retinal degeneration.人多能干细胞:理解和治疗视网膜变性的工具箱。
Mol Cell Neurosci. 2020 Sep;107:103523. doi: 10.1016/j.mcn.2020.103523. Epub 2020 Jul 4.
2
The cell biology of the retinal pigment epithelium.视网膜色素上皮细胞生物学
Prog Retin Eye Res. 2020 Feb 24:100846. doi: 10.1016/j.preteyeres.2020.100846.
3
EULAR recommendations for the management of Sjögren's syndrome with topical and systemic therapies.EULAR 推荐的干燥综合征局部和全身治疗管理建议。
WDR5B 的初步特征分析表明其在视网膜色素上皮细胞增殖中的作用。
Cells. 2024 Jul 13;13(14):1189. doi: 10.3390/cells13141189.
4
Looking for In Vitro Models for Retinal Diseases.寻找视网膜疾病的体外模型。
Int J Mol Sci. 2021 Sep 25;22(19):10334. doi: 10.3390/ijms221910334.
Ann Rheum Dis. 2020 Jan;79(1):3-18. doi: 10.1136/annrheumdis-2019-216114. Epub 2019 Oct 31.
4
Inflammatory Ocular Diseases and Sphingolipid Signaling.炎症性眼病与神经鞘脂信号通路
Adv Exp Med Biol. 2019;1159:139-152. doi: 10.1007/978-3-030-21162-2_8.
5
New therapies in development for the management of non-infectious uveitis: A review.正在开发的用于治疗非感染性葡萄膜炎的新疗法:综述。
Clin Exp Ophthalmol. 2019 Apr;47(3):396-417. doi: 10.1111/ceo.13511.
6
Toxicity and in vivo release profile of sirolimus from implants into the vitreous of rabbits' eyes.西罗莫司从植入物在兔眼玻璃体内的毒性及体内释放情况
Doc Ophthalmol. 2019 Feb;138(1):3-19. doi: 10.1007/s10633-018-9664-8. Epub 2018 Nov 19.
7
Human embryonic stem cell-derived retinal pigment epithelium transplants as a potential treatment for wet age-related macular degeneration.人胚胎干细胞来源的视网膜色素上皮移植作为湿性年龄相关性黄斑变性的一种潜在治疗方法。
Cell Discov. 2018 Sep 11;4:50. doi: 10.1038/s41421-018-0053-y. eCollection 2018.
8
Intravitreal Sirolimus for the Treatment of Noninfectious Uveitis: Evolution through Preclinical and Clinical Studies.玻璃体内注射西罗莫司治疗非感染性葡萄膜炎:临床前和临床研究的进展。
Ophthalmology. 2018 Dec;125(12):1984-1993. doi: 10.1016/j.ophtha.2018.06.015. Epub 2018 Jul 27.
9
Induced pluripotent stem cell-derived limbal epithelial cells (LiPSC) as a cellular alternative for in vitro ocular toxicity testing.诱导多能干细胞来源的角膜缘上皮细胞(LiPSC)作为体外眼毒性测试的细胞替代物。
PLoS One. 2017 Jun 22;12(6):e0179913. doi: 10.1371/journal.pone.0179913. eCollection 2017.
10
The use of in vivo, ex vivo, in vitro, computational models and volunteer studies in vision research and therapy, and their contribution to the Three Rs.体内、体外、离体模型、计算模型以及志愿者研究在视觉研究与治疗中的应用及其对“3R原则”的贡献
Altern Lab Anim. 2016 Jul;44(3):187-238. doi: 10.1177/026119291604400302.